CCMG & Garrod 2026 Joint Conference
Oxford Nanopore is exhibiting and presenting at the inaugural joint meeting between the Canadian College of Medical Geneticists (CCMG) and the Garrod Association. The conference will provide a national forum on genetic disorders with an emphasis on inborn errors of metabolism. It will foster collaboration among the metabolic and genetics communities, including physicians, nurses, dieticians, genetic counsellors, other allied health professionals, laboratory geneticists, laboratory staff, researchers, trainees, patient advocacy groups and industry partners.
Please visit us at our table top if you are able to attend the conference.
Breakfast Symposium
Toward the full genomic picture: real-time, multiomic profiling in rare disease and pediatric oncology with Oxford Nanopore sequencing
Join us at the Breakfast Symposium on Wednesday to hear how Oxford Nanopore Technologies continues to redefine genomic sequencing through a portfolio of innovations — from long-read and ultra-long-read sequencing to methylation detection, adaptive sampling, and telomere-to-telomere assembly. This session opens with Alex Lindell, Senior Director of Product Marketing giving an overview of these advances and their collective potential to transform rare disease genomics. Building on that foundation, our second presenter, Dr. Vincent-Philippe Lavallée of the CHU Sainte-Justine and the Université de Montréal will demonstrate the clinical power of real-time Oxford Nanopore sequencing in pediatric oncology. Dr. Lavallée will share a standardized ONT Whole-Genome Sequencing approach using Adaptive Sampling (AS-WGS) that consolidates multi-step diagnostic workflows into a single, rapid assay — delivering comprehensive tumor profiling when it matters most.
Date: Wednesday, June 10
Time: 8:30 pm-9:30 am EST
Location: Main Plenary Stage
Please contact events@nanoporetech.com with any questions.
Alex Lindell
- Job title
- Senior Director of Product Marketing
- Institution
- Oxford Nanopore Technologies
- Biography
Alex Lindell is Senior Director of Product Marketing at Oxford Nanopore Technologies. Prior to this role, he was Head of Genetic Disease Product Management at Oxford Nanopore. Alex previously held roles at Illumina and Lineagen where he focused on developing solutions to major unmet medical needs including rare and undiagnosed genetic diseases, neurodegenerative diseases, pulmonary diseases, pharmacogenomics, and transplant genomics.
Dr. Vincent-Philippe Lavallée
- Job title
- Principal Scientist & Associate Professor
- Institution
- CHU Sainte-Justine, Université de Montréal
- Biography
Vincent-Philippe Lavallée, MD PhD, is a hematologist‑oncologist at CHU Sainte‑Justine and Associate Professor at Université de Montréal. Trained in internal medicine, hematology, molecular biology, and computational biology, his work focuses on cancer genomics, particularly acute myeloid leukemia. He integrates exome, transcriptome, single‑cell, and long‑read sequencing into clinical diagnostics and contributes to provincial pediatric oncology testing. He also leads the Méta‑Plateforme de Génomique Intégrée, advancing precision medicine through liquid biopsy development and near real‑time genomic testing.
